

					

						November 23, 2017 - By Marguerite Chambers
Capital International Inc increased Seattle Genetics Inc (SGEN) stake by 55.5% reported in 2017Q2 SEC filing. Capital International Inc acquired 13,930 shares as Seattle Genetics Inc (SGEN)’s stock rose 1.68%. The Capital International Inc holds 39,030 shares with $2.02 million value, up from 25,100 last quarter. Seattle Genetics Inc now has $8.52 billion valuation. The stock increased 0.14% or $0.08 on November 22, reaching $59.13. About shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since November 23, 2016 and is uptrending. It has outperformed by 58.98% the S&P500.Peloton Wealth Strategists increased Novartis A G Spon Adr (NVS) stake by 1334.9% reported in 2017Q2 SEC filing. Peloton Wealth Strategists acquired 15,071 shares as Novartis A G Spon Adr (NVS)’s stock rose 4.17%. The Peloton Wealth Strategists holds 16,200 shares with $1.35M value, up from 1,129 last quarter. Novartis A G Spon Adr now has $220.40B valuation. The stock increased 0.25% or $0.21 on November 22, reaching $84.48. About 1.54M shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since November 23, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. Novartis Ag had 33 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Friday, March 24 by JP Morgan. Chardan Capital Markets initiated Novartis AG (ADR) (NYSE:NVS) on Tuesday, September 20 with “Buy” rating. Barclays Capital upgraded the shares of NVS in report on Friday, June 23 to “Hold” rating. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Overweight” rating by Morgan Stanley on Wednesday, July 26. On Friday, June 16 the stock rating was maintained by J P Morgan Chase Co with “Neutral”. The company was maintained on Thursday, June 22 by Leerink Swann. UBS downgraded the shares of NVS in report on Friday, April 1 to “Neutral” rating. The company was downgraded on Wednesday, March 23 by Leerink Swann. The company was maintained on Monday, September 11 by Cowen & Co. Credit Suisse downgraded the stock to “Neutral” rating in Wednesday, January 11 report.Among 18 analysts covering Seattle Genetics (NASDAQ:SGEN), 7 have Buy rating, 0 Sell and 11 Hold. Therefore 39% are positive. Seattle Genetics had 56 analyst reports since July 31, 2015 according to SRatingsIntel. JP Morgan maintained Seattle Genetics, Inc. (NASDAQ:SGEN) rating on Monday, October 30. JP Morgan has “Neutral” rating and $60 target. The firm has “Hold” rating by Piper Jaffray given on Monday, July 24. The company was maintained on Monday, October 23 by Needham. Morgan Stanley initiated the shares of SGEN in report on Wednesday, September 7 with “Overweight” rating. The rating was initiated by Oppenheimer on Tuesday, October 10 with “Hold”. The firm has “Hold” rating by J.P. Morgan given on Thursday, June 8. Leerink Swann maintained Seattle Genetics, Inc. (NASDAQ:SGEN) on Friday, August 14 with “Outperform” rating. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) earned “Outperform” rating by RBC Capital Markets on Tuesday, December 6. The firm has “Underperform” rating given on Friday, February 10 by Bank of America. The stock has “Hold” rating by Oppenheimer on Wednesday, November 8.Capital International Inc decreased Monsanto Co (NYSE:MON) stake by 15,750 shares to 39,800 valued at $4.71M in 2017Q2. It also reduced Marsh And Mclennan Companies Inc (NYSE:MMC) stake by 10,000 shares and now owns 66,500 shares. Canadian National Railway Co (Usd) (NYSE:CNI) was reduced too. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.


		var data = "63557954";
		document.write('<ins class="adsbygoogle" style="background-color:transparent; display:inline-block;width:300px;height:600px;" data-ad-client="ca-pub-16900'+data+'675" data-ad-slot="8925061741"></ins>')
	
(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});